Saanich-based pharmaceutical company stocks double in value after successful lupus drug trial

More than 40 per cent of patients using voclosporin saw improvements in kidney function

Saanich-based pharmaceutical company, Aurinia Pharmaceuticals, saw share values soar on Thursday after success with clinical trials for a new lupus drug.

On Dec. 4, the company announced that results from the AURORA Phase 3 drug trials for voclosporin had been successful in treating kidney inflammation in patients with lupus nephritis – an autoimmune disease.

Aurinia’s chief medical officer Neil Solomons explained that patients with lupus can experience “irreversible kidney damage” that can lead to kidney failure and death.

READ ALSO: Saanich biotech company secures $52M US for global drug study

The study included 357 patients from 27 countries living with lupus and the results showed that participants using voclosporin experienced a “renal response rate” of 40.8 per cent while just 22.5 per cent of participants in the control group – those who didn’t receive the drug – saw improvements.

Data also indicated that the group taking voclosporin saw no more adverse events than the group receiving standard lupus treatment, noted Brad Rovin, chief of the nephrology division at the Ohio State University Wexner Medical Centre.

Following the announcement of the drug’s successful Phase 3 trial, the company’s share price exploded on Thursday, rising from Wednesday’s close of $11.13 per share to touch a 52-week high of $23.04 before closing at $19.75. Its shares have risen from a 52-week low of $4.70 to close Friday at $20.48 – a gain of 336 per cent, driving the company’s market cap to $1.93 billion.

Lupus has historically been difficult to treat and new treatment options were needed, said Stevan Gibson, president and CEO of the Lupus Foundation of America. Voclosporin is the first effective therapeutic treatment option and the successful trial marks a step forward in treating the potentially deadly disease, he noted.

READ ALSO: Mental health call temporarily shuts down Trans Canada Highway in View Royal

Aurinia co-founder Mike Martin noted that after eight years of hard work, staff are excited about the outcomes of the trial. he emphasized that the drug’s success will be significant for people living with lupus – close to 1 million people worldwide.

“It was a pleasure to share the results,” Martin said. Given the data, he wasn’t surprised by the uptake in stock.

He emphasized how grateful the company is for the participants and for the opportunity to change the trajectory of people’s lives.

The company is planning to put the drug on the market as early as 2021, but first it must pass though the U.S. Food and Drug Administration (FDA) process. The drug was given a fast track by the FDA in 2016 and the company plans to submit to the FDA in early 2020.

With files from Paul Bucci.


@devonscarlett
Like us on Facebook and follow us on Twitter.

devon.bidal@saanichnews.com

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

Hydro pole fire closes portion of Metchosin Road in Colwood

Motorists are advised to avoid the area of Metchosin Road near Royal Bay

Saanich roads doused in more than 300 tonnes of salt during snowstorm

Crews cleared roads around the clock during the mid-January storm

Esquimalt arsonist sentenced to two years in jail, thanks police, defence lawyer and taxpayers

Wei Li was convicted of intentionally lighting his rental property on fire in October 2017

‘We thought it was an earthquake,’ homeowners okay after tree falls

Mature tree falls on roof of Victoria Avenue house

VIDEO: The Victoria byelection leads a selection of today’s news stories

A selection of Greater Victoria top stories for Jan. 17

Theft victim confronts suspects with baseball bat on Vancouver Island

RCMP in Nanaimo seek to identify of two people alleged to have used a stolen credit card

Closed mills, housing surge support a positive forecast for lumber industries

B.C. lumber producers have closed mills accounting for 18% of province’s capacity, RBC report says

Kelowna’s ‘Baby Mary’ finds biological parents after more than 30 years

Geneologist and DNA test helped her connect with her biological parents

SOOKE HISTORY: Remembering Salvatore (Sam) Pasta

Salvatore (Sam) Pasta lived life to the fullest

Clerk bruised, traumatized after armed robbery at Nanaimo liquor store

Few details on male suspect in Wednesday incident, says Nanaimo RCMP

One last blast of winter tonight for parts of the Island before temperatures on the rise

A snowfall warning is in effect Friday including east Vancouver Island.

POLL: Has the recent snow had an impact on your daily life?

Old Man Winter had Greater Victoria in his icy grip this week.… Continue reading

Greater Victoria Crime Stoppers wanted list for the week of Jan. 14

Greater Victoria Crime Stoppers is seeking the public’s help in locating the… Continue reading

Most Read